111 related articles for article (PubMed ID: 11420891)
1. Bioinversion of ibuprofen enantiomers after administration in dogs: estimation of a novel index.
Frihmat R; Cardot JM; Beyssac E; Boucher M; Aiache JM
Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):205-11. PubMed ID: 11420891
[TBL] [Abstract][Full Text] [Related]
2. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of ibuprofen bioinversion by simulation.
Romero AJ; Rackley RJ; Rhodes CT
Chirality; 1991; 3(5):418-21. PubMed ID: 1756097
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans.
Cheng H; Rogers JD; Demetriades JL; Holland SD; Seibold JR; Depuy E
Pharm Res; 1994 Jun; 11(6):824-30. PubMed ID: 7937520
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective pharmacokinetics of ibuprofen in rats: effect of enantiomer-enantiomer interaction in plasma protein binding.
Itoh T; Maruyama J; Tsuda Y; Yamada H
Chirality; 1997; 9(4):354-61. PubMed ID: 9275314
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ibuprofen enantiomers in rats after intravenous and oral administration of ibuprofen arginate.
Wang XL; Han J; Zhang D; Liu HC
Yao Xue Xue Bao; 2012 Jan; 47(1):88-93. PubMed ID: 22493811
[TBL] [Abstract][Full Text] [Related]
7. Preclinical and clinical development of dexketoprofen.
Mauleón D; Artigas R; García ML; Carganico G
Drugs; 1996; 52 Suppl 5():24-45; discussion 45-6. PubMed ID: 8922555
[TBL] [Abstract][Full Text] [Related]
8. The oral bioavailability of ibuprofen enantiomers in broiler chickens.
Vermeulen B; Remon JP
J Vet Pharmacol Ther; 2001 Apr; 24(2):105-9. PubMed ID: 11442784
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ibuprofen enantiomers in children with cystic fibrosis.
Dong JQ; Ni L; Scott CS; Retsch-Bogart GZ; Smith PC
J Clin Pharmacol; 2000 Aug; 40(8):861-8. PubMed ID: 10934670
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates.
Jamali F; Singh NN; Pasutto FM; Russell AS; Coutts RT
Pharm Res; 1988 Jan; 5(1):40-3. PubMed ID: 3244607
[TBL] [Abstract][Full Text] [Related]
11. Fasting and postprandial disposition of R(-)- and S(+)-ibuprofen following oral administration of racemic drug in healthy individuals.
Siemon D; de Vries JX; Stötzer F; Walter-Sack I; Dietl R
Eur J Med Res; 1997 May; 2(5):215-9. PubMed ID: 9153347
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ibuprofen enantiomers in dogs.
Beck WS; Geisslinger G; Engler H; Brune K
Chirality; 1991; 3(3):165-9. PubMed ID: 1911048
[TBL] [Abstract][Full Text] [Related]
13. Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats.
Walser S; Hruby R; Hesse E; Heinzl H; Mascher H
Arzneimittelforschung; 1997 Jun; 47(6):750-4. PubMed ID: 9239454
[TBL] [Abstract][Full Text] [Related]
14. Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration.
Kyllönen M; Olkkola KT; Seppälä T; Ryhänen P
Paediatr Anaesth; 2005 Jul; 15(7):566-73. PubMed ID: 15960640
[TBL] [Abstract][Full Text] [Related]
15. Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers.
Tan SC; Patel BK; Jackson SH; Swift CG; Hutt AJ
Xenobiotica; 2002 Aug; 32(8):683-97. PubMed ID: 12296989
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration.
Suri A; Grundy BL; Derendorf H
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):1-8. PubMed ID: 9021434
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit.
González-Peñas E; Echeverría HC; Mosquera J; Esteras A; Bruseghini L
Arzneimittelforschung; 2003; 53(11):786-92. PubMed ID: 14677375
[TBL] [Abstract][Full Text] [Related]
18. Influence of physicochemical properties on the in vitro skin permeation of the enantiomers, racemate, and eutectics of ibuprofen for enhanced transdermal drug delivery.
Yuan X; Capomacchia AC
J Pharm Sci; 2013 Jun; 102(6):1957-1969. PubMed ID: 23589422
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans.
Evans AM; Nation RL; Sansom LN; Bochner F; Somogyi AA
Biopharm Drug Dispos; 1990; 11(6):507-18. PubMed ID: 2207301
[TBL] [Abstract][Full Text] [Related]
20. Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.
Ochoa D; Prieto-Pérez R; Román M; Talegón M; Rivas A; Galicia I; Abad-Santos F; Cabaleiro T
Pharmacogenomics; 2015; 16(9):939-48. PubMed ID: 26122864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
